Clinical Trial Update: A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

View source ↗

Summary

Clinical trial update for cerebral adrenoleukodystrophy (CALD) patients treated with elivaldogene autotemcel; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Adrenoleukodystrophy

Drugs mentioned

• Elivaldogene Autotemcel (elivaldogene autotemcel)

Snippet

Sponsor: Genetix Biotherapeutics Inc. | Conditions: Cerebral Adrenoleukodystrophy (CALD) | Status: RECRUITING